[go: up one dir, main page]

GB0026015D0 - Cancer treatment - Google Patents

Cancer treatment

Info

Publication number
GB0026015D0
GB0026015D0 GBGB0026015.8A GB0026015A GB0026015D0 GB 0026015 D0 GB0026015 D0 GB 0026015D0 GB 0026015 A GB0026015 A GB 0026015A GB 0026015 D0 GB0026015 D0 GB 0026015D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0026015.8A
Other versions
GB2361642A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Healthcare AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GB0026015A priority Critical patent/GB2361642A/en
Publication of GB0026015D0 publication Critical patent/GB0026015D0/en
Publication of GB2361642A publication Critical patent/GB2361642A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0026015A 2000-10-24 2000-10-24 Estrogen receptor beta (ERbeta) agonists for use in cancer treatment Withdrawn GB2361642A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0026015A GB2361642A (en) 2000-10-24 2000-10-24 Estrogen receptor beta (ERbeta) agonists for use in cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0026015A GB2361642A (en) 2000-10-24 2000-10-24 Estrogen receptor beta (ERbeta) agonists for use in cancer treatment

Publications (2)

Publication Number Publication Date
GB0026015D0 true GB0026015D0 (en) 2000-12-13
GB2361642A GB2361642A (en) 2001-10-31

Family

ID=9901878

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0026015A Withdrawn GB2361642A (en) 2000-10-24 2000-10-24 Estrogen receptor beta (ERbeta) agonists for use in cancer treatment

Country Status (1)

Country Link
GB (1) GB2361642A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101697D0 (en) * 2001-05-14 2001-05-14 Astrazeneca Ab Pharmaceutical combination
ES2286322T3 (en) 2001-11-19 2007-12-01 Eli Lilly And Company BENZOPIRIANOS AS SELECTIVE AGOSNISTS OF BETA STROGEN RECEPTORS.
WO2004094400A2 (en) 2003-04-21 2004-11-04 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
DE602004025460D1 (en) 2003-04-21 2010-03-25 Lilly Co Eli SUBSTITUTED BENZOPYRANES AS SELECTIVE ANTAGONISTS ON THE OSTROGEN RECEPTOR BETA
CN101052641A (en) 2004-09-07 2007-10-10 惠氏公司 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
CZ2008275A3 (en) 2008-05-05 2009-05-06 Prírodovedecká Fakulta Uk Estrogen receptors alpha and beta ligands, method of their preparation and pharmaceutical compositions comprising thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048790A1 (en) * 1997-04-28 1998-11-05 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
AU766648B2 (en) * 1999-03-17 2003-10-23 Axys Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
TR200102992T2 (en) * 1999-04-16 2004-12-21 Astrazeneca Ab ß estrogen receptor ligands.
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Also Published As

Publication number Publication date
GB2361642A (en) 2001-10-31

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
GB0028264D0 (en) Well treatment
GB0028269D0 (en) Well treatment
GB0028429D0 (en) Therapy
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
GB0030845D0 (en) Novel treatment
GB0001710D0 (en) Therapeutic treatment
AU2001257325A1 (en) Cancer treatment
GB0026015D0 (en) Cancer treatment
AU2096002A (en) Therapeutic treatment
GB9804361D0 (en) Cancer treatment
GB0031321D0 (en) Treatment
AU2001289127A1 (en) Tumor treatment
GB0029125D0 (en) Novel treatment
EP1463511A4 (en) Combination cancer therapy
AU2001257168A1 (en) Cancer treatment
GB0027780D0 (en) Treating cancer
GB0019728D0 (en) Novel treatment
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
GB0008161D0 (en) Treatment of cancer
GB0012760D0 (en) Treatment
GB0020669D0 (en) Alopica treatment
GB0017495D0 (en) Treatment

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)